# Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan

> **NCT07207434** · PHASE2 · RECRUITING · sponsor: **Aga Khan University** · enrollment: 144 (estimated)

## Conditions studied

- Environmental Enteric Dysfunction (EED)
- Stunting

## Interventions

- **DRUG:** Oral Vancomycin
- **DRUG:** VE818
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07207434
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-30
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2025-10-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07207434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07207434, "Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07207434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*